These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16685222)

  • 21. A comparison of two multiple-characteristic decision-making models for the comparison of antihypertensive drug classes: Simple Additive Weighting (SAW) and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS).
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Am J Cardiovasc Drugs; 2006; 6(4):251-8. PubMed ID: 16913826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing pattern of antihypertensive drugs by family physicians and general practitioners in the primary care setting in Bahrain.
    Sequeira RP; Jassim KA; Damanhori AH; Mathur VS
    J Eval Clin Pract; 2002 Nov; 8(4):407-14. PubMed ID: 12421390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy.
    Krogager ML; Mortensen RN; Lund PE; Bøggild H; Hansen SM; Kragholm K; Aasbjerg K; Søgaard P; Torp-Pedersen C
    Hypertension; 2020 Apr; 75(4):966-972. PubMed ID: 32114850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
    J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Player MS; Gill JM; Fagan HB; Mainous AG
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12):860-4. PubMed ID: 17170611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
    Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
    Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.
    Cataldi M; di Geronimo O; Trio R; Scotti A; Memoli A; Capone D; Guida B
    BMC Pharmacol Toxicol; 2016 Mar; 17():9. PubMed ID: 26980335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands.
    Li X; Bijlsma MJ; Bos JHJ; Schuiling-Veninga CCM; Hak E
    BMJ Open; 2023 Aug; 13(8):e068721. PubMed ID: 37558444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation?
    Sonawane KB; Qian J; Garza KB; Wright BM; Zeng P; Ganduglia-Cazaban CM; Hansen RA
    J Hypertens; 2016 Mar; 34(3):548-57; discussion 557. PubMed ID: 26820480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use and adverse reactions of antihypertensive drugs in Spain. Part I of the RAAE Study.
    Aranda P; Tamargo J; Aranda FJ; Luque M; López-Garcia-Franco A
    Blood Press Suppl; 1997; 1():11-6. PubMed ID: 9285102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia.
    Maclure M; Dormuth C; Naumann T; McCormack J; Rangno R; Whiteside C; Wright JM
    Lancet; 1998 Sep; 352(9132):943-8. PubMed ID: 9752816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
    Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study.
    Ruths S; Bakken MS; Ranhoff AH; Hunskaar S; Engesæter LB; Engeland A
    BMC Geriatr; 2015 Dec; 15():153. PubMed ID: 26626043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate and determinants of 10-year persistence with antihypertensive drugs.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    J Hypertens; 2005 Nov; 23(11):2101-7. PubMed ID: 16208154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project.
    Bøg-Hansen E; Lindblad U; Ranstam J; Melander A; Råstam L
    Pharmacoepidemiol Drug Saf; 2002; 11(1):45-54. PubMed ID: 11998551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano.
    Crucitti A; Cecchi E; Gensini GF; Simone I; Conti A; Gialloni S; Pedone C; Pahor M; Mugelli A
    Pharmacol Res; 2000 Feb; 41(2):249-53. PubMed ID: 10623493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.